Detalhe da pesquisa
1.
Cancer immunotherapy via targeted TGF-ß signalling blockade in TH cells.
Nature
; 587(7832): 121-125, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33087933
2.
Immunotherapy with anti-GD2 monoclonal antibody in infants with high-risk neuroblastoma.
Int J Cancer
; 152(2): 259-266, 2023 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35913764
3.
Stage 4N neuroblastoma before and during the era of anti-GD2 immunotherapy.
Int J Cancer
; 153(12): 2019-2031, 2023 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37602920
4.
Clinical outcomes of pediatric patients receiving multimodality treatment of second central nervous system relapse of neuroblastoma.
Pediatr Blood Cancer
; 70(2): e30075, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36349892
5.
Human Cytomegalovirus Infection Promotes Expansion of a Functionally Superior Cytoplasmic CD3+ NK Cell Subset with a Bcl11b-Regulated T Cell Signature.
J Immunol
; 207(10): 2534-2544, 2021 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34625521
6.
Promise and Challenges of T Cell Immunotherapy for Osteosarcoma.
Int J Mol Sci
; 24(15)2023 Aug 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37569894
7.
KMT2A-MAML2 rearrangement emerged and regressed during neuroblastoma therapy without leukemia after 12.8-year follow-up.
Pediatr Blood Cancer
; 69(1): e29344, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34550633
8.
Engineered Cells as a Test Platform for Radiohaptens in Pretargeted Imaging and Radioimmunotherapy Applications.
Bioconjug Chem
; 32(4): 649-654, 2021 04 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-33819023
9.
IntraOmmaya compartmental radioimmunotherapy using 131I-omburtamab-pharmacokinetic modeling to optimize therapeutic index.
Eur J Nucl Med Mol Imaging
; 48(4): 1166-1177, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33047248
10.
Potent antitumor effect of T cells armed with anti-GD2 bispecific antibody.
Pediatr Blood Cancer
; 68(7): e28971, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33844437
11.
Ganglioside GD2 Enhances the Malignant Phenotypes of Melanoma Cells by Cooperating with Integrins.
Int J Mol Sci
; 23(1)2021 Dec 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-35008849
12.
An N-Acetylgalactosamino Dendron-Clearing Agent for High-Therapeutic-Index DOTA-Hapten Pretargeted Radioimmunotherapy.
Bioconjug Chem
; 31(3): 501-506, 2020 03 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-31891487
13.
Reduced-dose craniospinal irradiation for central nervous system relapsed neuroblastoma.
Pediatr Blood Cancer
; 67(9): e28364, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32608559
14.
Targeted radioimmunotherapy for embryonal tumor with multilayered rosettes.
J Neurooncol
; 143(1): 101-106, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30879172
15.
Convection-enhanced delivery for diffuse intrinsic pontine glioma: a single-centre, dose-escalation, phase 1 trial.
Lancet Oncol
; 19(8): 1040-1050, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29914796
16.
Treatment and outcome of adult-onset neuroblastoma.
Int J Cancer
; 143(5): 1249-1258, 2018 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29574715
17.
Dose-escalation is needed for gross disease in high-risk neuroblastoma.
Pediatr Blood Cancer
; 65(7): e27009, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29469198
18.
A phase II study of radioimmunotherapy with intraventricular 131 I-3F8 for medulloblastoma.
Pediatr Blood Cancer
; 65(1)2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-28940863
19.
A phase I/Ib trial targeting the Pi3k/Akt pathway using perifosine: Long-term progression-free survival of patients with resistant neuroblastoma.
Int J Cancer
; 140(2): 480-484, 2017 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27649927
20.
Combination of bevacizumab, irinotecan, and temozolomide for refractory or relapsed neuroblastoma: Results of a phase II study.
Pediatr Blood Cancer
; 64(8)2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28111925